Ventana Medical Systems Inc (VMS), a subsidiary of F. Hoffmann-La Roche Ltd is a manufacturer of tissue-based diagnostic solutions for healthcare market. The company develops cancer diagnostic solutions for breast pathology, cervical diagnostics, colorectal pathology, special stains, lung pathology, dermatopathology, hematopathology and prostate pathology. The company offers detection systems such as ultraVIEW SISH Detection Kit, ISH iVIEW Blue Plus detection kit, ultraView Red ISH DIG detection kit and ultraView SISH DNP detection kit.VMS also offers technical and application support services. The company markets its products through its channel of network distributors. VMS is headquartered in Tucson, Arizona, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Ventana Medical Systems Inc - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Our reports have been used by over 10K customers, including:
Uterine Cancer Therapeutics & Diagnostics Market Report Overview Uterine Cancer Therapeutics & Diagnostics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Uterine Cancer Therapeutics & Diagnostics market types and applications. It is...
Diagnostic Specialty Antibodies Market Report Overview Diagnostic Specialty Antibodies market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Diagnostic Specialty Antibodies market types and applications. It is a focused study on Diagnostic...
STD Diagnostics Market Report Overview STD Diagnostics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across STD Diagnostics market types and applications. It is a focused study on STD Diagnostics market space including global and regional...
Transplant Diagnostics Market Report Overview Transplant Diagnostics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Transplant Diagnostics market types and applications. It is a focused study on Transplant Diagnostics market space...
The women’s health diagnostics market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period. In the past decade, the demand for various health diagnostic tests has increased significantly across the globe. Currently, the market is mainly driven by growing awareness about...
The global point of care diagnostrics market size is projected to reach USD 50.6 billion by 2025 from USD 29.5 billion in 2020, at a CAGR of 11.4%. Factors such as the technological advancements in point of care devices in the market are propelling the growth of the market. Additionally, rising cases of investments from both private and public...
The major factors responsible for the growth of the mammography market include the growing prevalence of breast cancer, technological advancements in the field of breast imaging, and investment from various organizations in breast cancer screening campaigns. - According to the Centers for Disease Control and Prevention (CDC) reports,...
The global chromatography instruments market is projected to reach USD 11.0 billion by 2025 from USD 8.6 billion in 2020 at a CAGR of 5.1%. Growth in the chromatography instruments market can be attributed to increasing investments by pharma and biotech companies in R&D activities, growing demand for hyphenated chromatography techniques, and...
200 pages •
By The Business Research Company
• Nov 2020
Clinical Oncology Next Generation Sequencing Market Global Report 2020-30: Covid 19 Growth And Change provides the strategists, marketers and senior management with the critical information they need to assess the global clinical oncology next generation sequencing market. This report focuses on clinical oncology next generation sequencing...
Report Scope: The scope of this report is broad and covers the components available in the polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market and potential end-users. Revenue forecasts from 2020 to 2025 are given for types of kits and equipment, with estimated value derived from the revenues of manufacturers. The...
Molecular Diagnostics
Diagnostics
Infectious Disease
World
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.